CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Statement of Comprehensive Income [Abstract]
Revenue	$ 887	$ 1,607	$ 3,628	$ 3,758
Operating expenses:
Cost of goods sold (exclusive of depreciation and amortization)	2,041	2,585	6,609	8,270
Research and development	5,153	3,545	14,015	12,325
Selling, general and administrative	10,012	8,016	30,765	24,570
Depreciation and amortization	3,546	1,313	6,348	3,926
Total operating expenses	20,752	15,459	57,737	49,091
Operating loss	(19,865)	(13,852)	(54,109)	(45,333)
Other income (expense):
Interest expense, net	(3,179)	(2,217)	(8,937)	(6,706)
Debt extinguishment loss			(14,434)
Change in fair value of warrants	4,801	2,143	2,006	(19,523)
Change in fair value of derivative liability	18,774		(36,407)
Other income (loss), net	(2)	343	(9,264)	2,091
Income (loss) before income taxes	529	(13,583)	(121,145)	(69,471)
Provision for income taxes	(46)	(26)	(146)	(138)
Net income (loss)	483	(13,609)	(121,291)	(69,609)
Foreign currency translation adjustment	(65)	1,005	3,076	304
Comprehensive income (loss)	418	(12,604)	(118,215)	(69,305)
Net income (loss)	483	(13,609)	(121,291)	(69,609)
Net Income (loss) attributable to common stockholders – basic	483	(13,609)	(121,291)	(69,609)
Net Income (loss) attributable to common stockholders – diluted	$ (18,212)	$ (13,609)	$ (123,297)	$ (69,609)
Weighted average of shares outstanding – basic (in shares)	133,335	126,429	131,913	118,978
Weighted average of shares outstanding – diluted (in shares)	149,557	126,429	132,535	118,978
Net Income (loss) attributable to common stockholders per share – basic (in dollars per share)	$ 0	$ (0.11)	$ (0.92)	$ (0.59)
Net Income (loss) attributable to common stockholders per share – diluted (in dollars per share)	$ (0.12)	$ (0.11)	$ (0.93)	$ (0.59)